Prasco signs pact with Shionogi to market generic furadantin oral suspension
News | 24 August 2011
Prasco Laboratories, the Authorized Generics company, announced it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Nitrofurantoin Oral Suspension, the Authorized Generic version of ...
Click on the link to read the full article at pharmabiz.com
(This link will open in a new window)
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
